BIOMARIN PHARMACEUTICAL INC Costs and Expenses
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Costs and Expenses of $878.79 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2026-08-06
- BIOMARIN PHARMACEUTICAL INC costs and expenses for the quarter ending 2026-06-30 was $878.79M, a 60.21% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC costs and expenses for the quarter ending 2026-03-31 was $636.57M, a 22.12% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC costs and expenses for the quarter ending 2025-12-31 was $919.17M, a 56.88% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC costs and expenses for the quarter ending 2025-09-30 was $822.83M, a 30.23% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC costs and expenses for fiscal 2025 was $2.81B, a 18.66% increase from fiscal 2024.
- BIOMARIN PHARMACEUTICAL INC costs and expenses for fiscal 2024 was $2.37B, a 6.10% increase from fiscal 2023.
- BIOMARIN PHARMACEUTICAL INC costs and expenses for fiscal 2023 was $2.23B, a 15.42% increase from fiscal 2022.
- BIOMARIN PHARMACEUTICAL INC costs and expenses for fiscal 2022 was $1.94B, a 0.33% increase from fiscal 2021.
| Period end | Costs and Expenses 3 month | Costs and Expenses 3 month as first filed | Costs and Expenses 6 month | Costs and Expenses 6 month as first filed | Costs and Expenses 9 month | Costs and Expenses 9 month as first filed | Costs and Expenses 12 month | Costs and Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $878.79M 10-Q · filed 2026-08-06 | $1.52B 10-Q · filed 2026-08-06 | $2.43B derived: sum of 3 quarters · filed 2026-08-06 | $3.26B derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $636.57M 10-Q · filed 2026-05-05 | $1.56B derived: sum of 2 quarters · filed 2026-05-05 | $2.38B derived: sum of 3 quarters · filed 2026-05-05 | $2.93B derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $919.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.74B derived: sum of 2 quarters · filed 2026-02-26 | $2.29B derived: sum of 3 quarters · filed 2026-08-06 | $2.81B 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $822.83M 10-Q · filed 2025-10-28 | $1.37B derived: sum of 2 quarters · filed 2026-08-06 | $1.89B 10-Q · filed 2025-10-28 | $2.48B derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $548.52M 10-Q · filed 2026-08-06 | $1.07B 10-Q · filed 2026-08-06 | $1.66B derived: sum of 3 quarters · filed 2026-08-06 | $2.29B derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $521.25M 10-Q · filed 2026-05-05 | $1.11B derived: sum of 2 quarters · filed 2026-05-05 | $1.74B derived: sum of 3 quarters · filed 2026-05-05 | $2.33B derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $585.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.22B derived: sum of 2 quarters · filed 2026-02-26 | $1.81B derived: sum of 3 quarters · filed 2026-02-26 | $2.37B 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $631.85M 10-Q · filed 2025-10-28 | $1.22B derived: sum of 2 quarters · filed 2025-10-28 | $1.78B 10-Q · filed 2025-10-28 | $2.40B derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $591.58M 10-Q · filed 2025-08-05 | $1.15B 10-Q · filed 2025-08-05 | $1.77B derived: sum of 3 quarters · filed 2026-02-26 | $2.32B derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $560.37M 10-Q · filed 2025-05-02 | $1.18B derived: sum of 2 quarters · filed 2026-02-26 | $1.73B derived: sum of 3 quarters · filed 2026-02-26 | $2.26B derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $618.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.17B derived: sum of 2 quarters · filed 2026-02-26 | $1.70B derived: sum of 3 quarters · filed 2026-02-26 | $2.23B 10-K · filed 2026-02-26 | $2.26B 10-K · filed 2024-02-26 | |||
| 2023-09-30 | $550.80M 10-Q · filed 2024-10-31 | $555.67M 10-Q · filed 2023-11-02 | $1.08B derived: sum of 2 quarters · filed 2024-10-31 | $1.61B 10-Q · filed 2024-10-31 | $1.63B 10-Q · filed 2023-11-02 | $2.17B derived: sum of 4 quarters · filed 2025-02-24 | ||
| 2023-06-30 | $529.71M 10-Q · filed 2024-08-05 | $536.40M 10-Q · filed 2023-08-02 | $1.06B 10-Q · filed 2024-08-05 | $1.07B 10-Q · filed 2023-08-02 | $1.61B derived: sum of 3 quarters · filed 2025-02-24 | $2.12B derived: sum of 4 quarters · filed 2025-02-24 | ||
| 2023-03-31 | $534.01M 10-Q · filed 2024-04-26 | $537.07M 10-Q · filed 2023-04-28 | $1.08B derived: sum of 2 quarters · filed 2025-02-24 | $1.59B derived: sum of 3 quarters · filed 2025-02-24 | $2.09B derived: sum of 4 quarters · filed 2025-02-24 | |||
| 2022-12-31 | $550.63M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24 | $1.06B derived: sum of 2 quarters · filed 2025-02-24 | $1.55B derived: sum of 3 quarters · filed 2025-02-24 | $1.94B 10-K · filed 2025-02-24 | $1.95B 10-K · filed 2023-02-27 | |||
| 2022-09-30 | $507.76M 10-Q · filed 2023-11-02 | $1.00B derived: sum of 2 quarters · filed 2023-11-02 | $1.38B 10-Q · filed 2023-11-02 | $1.90B derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2022-06-30 | $494.65M 10-Q · filed 2023-08-02 | $876.68M 10-Q · filed 2023-08-02 | $1.39B derived: sum of 3 quarters · filed 2024-02-26 | $1.85B derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2022-03-31 | $382.03M 10-Q · filed 2023-04-28 | $897.72M derived: sum of 2 quarters · filed 2024-02-26 | $1.36B derived: sum of 3 quarters · filed 2024-02-26 | $1.85B derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2021-12-31 | $515.69M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $977.65M derived: sum of 2 quarters · filed 2024-02-26 | $1.47B derived: sum of 3 quarters · filed 2024-02-26 | $1.93B 10-K · filed 2024-02-26 | ||||
| 2021-09-30 | $461.96M 10-Q · filed 2022-10-28 | $951.98M derived: sum of 2 quarters · filed 2022-10-28 | $1.41B 10-Q · filed 2022-10-28 | $1.92B derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-06-30 | $490.02M 10-Q · filed 2022-08-04 | $950.97M 10-Q · filed 2022-08-04 | $1.45B derived: sum of 3 quarters · filed 2023-02-27 | $1.99B derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-03-31 | $460.94M 10-Q · filed 2022-04-29 | $964.58M derived: sum of 2 quarters · filed 2023-02-27 | $1.50B derived: sum of 3 quarters · filed 2023-02-27 | $1.97B derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2020-12-31 | $503.63M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $1.04B derived: sum of 2 quarters · filed 2023-02-27 | $1.51B derived: sum of 3 quarters · filed 2023-02-27 | $1.90B 10-K · filed 2023-02-27 | $1.90B 10-K · filed 2021-02-26 | |||
| 2020-09-30 | $532.73M 10-Q · filed 2021-10-29 | $1.00B derived: sum of 2 quarters · filed 2021-10-29 | $1.40B 10-Q · filed 2021-10-29 | $1.86B derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-06-30 | $470.43M 10-Q · filed 2021-07-30 | $867.54M 10-Q · filed 2021-07-30 | $1.33B derived: sum of 3 quarters · filed 2022-02-25 | $1.79B derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-03-31 | $397.11M 10-Q · filed 2021-04-30 | $860.71M derived: sum of 2 quarters · filed 2022-02-25 | $1.32B derived: sum of 3 quarters · filed 2022-02-25 | $1.75B derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | $463.61M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $920.69M derived: sum of 2 quarters · filed 2022-02-25 | $1.35B derived: sum of 3 quarters · filed 2022-02-25 | $1.80B 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $457.09M 10-Q · filed 2020-11-06 | $886.20M derived: sum of 2 quarters · filed 2020-11-06 | $1.34B 10-Q · filed 2020-11-06 | $1.73B derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-06-30 | $429.12M 10-Q · filed 2020-08-05 | $883.81M 10-Q · filed 2020-08-05 | $1.28B derived: sum of 3 quarters · filed 2021-02-26 | $1.68B derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-03-31 | $454.70M 10-Q · filed 2020-05-01 | $846.06M derived: sum of 2 quarters · filed 2021-02-26 | $1.25B derived: sum of 3 quarters · filed 2021-02-26 | $1.65B derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2018-12-31 | $391.36M derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-02-26 | $798.81M derived: sum of 2 quarters · filed 2021-02-26 | $1.20B derived: sum of 3 quarters · filed 2021-02-26 | $1.61B 10-K · filed 2021-02-26 | ||||
| 2018-09-30 | $407.45M 10-Q/A · filed 2019-11-04 | $805.55M derived: sum of 2 quarters · filed 2019-11-04 | $1.22B 10-Q/A · filed 2019-11-04 | $1.52B derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | $398.11M 10-Q · filed 2019-08-02 | $815.93M 10-Q · filed 2019-08-02 | $1.12B derived: sum of 3 quarters · filed 2020-02-27 | $1.46B derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | $417.82M 10-Q · filed 2019-04-29 | $718.08M derived: sum of 2 quarters · filed 2020-02-27 | $1.07B derived: sum of 3 quarters · filed 2020-02-27 | $1.42B derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | $300.26M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $648.13M derived: sum of 2 quarters · filed 2020-02-27 | $1.00B derived: sum of 3 quarters · filed 2020-02-27 | $1.33B 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | $347.88M 10-Q · filed 2018-10-26 | $704.13M derived: sum of 2 quarters · filed 2018-10-26 | $1.03B 10-Q · filed 2018-10-26 | $1.42B derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-06-30 | $356.26M 10-Q · filed 2018-08-03 | $680.21M 10-Q · filed 2018-08-03 | $1.07B derived: sum of 3 quarters · filed 2019-02-28 | $1.41B derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-03-31 | $323.95M 10-Q · filed 2018-04-27 | $713.66M derived: sum of 2 quarters · filed 2019-02-28 | $1.05B derived: sum of 3 quarters · filed 2019-02-28 | $1.93B derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2016-12-31 | $389.71M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $729.69M derived: sum of 2 quarters · filed 2019-02-28 | $1.60B derived: sum of 3 quarters · filed 2019-02-28 | $1.92B 10-K · filed 2019-02-28 | ||||
| 2016-09-30 | $339.98M 10-Q · filed 2017-10-31 | $1.21B derived: sum of 2 quarters · filed 2017-10-31 | $1.53B 10-Q · filed 2017-10-31 | $1.66B derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-06-30 | $872.94M 10-Q · filed 2017-08-02 | $1.19B 10-Q · filed 2017-08-02 | $1.32B derived: sum of 3 quarters · filed 2018-02-26 | $1.61B derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-03-31 | $317.65M 10-Q · filed 2017-05-04 | $444.27M derived: sum of 2 quarters · filed 2018-02-26 | $735.05M derived: sum of 3 quarters · filed 2018-02-26 | $1.05B derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2015-12-31 | $126.62M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $417.39M derived: sum of 2 quarters · filed 2018-02-26 | $731.82M derived: sum of 3 quarters · filed 2018-02-26 | $1.00B 10-K · filed 2018-02-26 | ||||
| 2015-09-30 | $290.78M 10-Q · filed 2016-11-03 | $605.20M derived: sum of 2 quarters · filed 2016-11-03 | $873.98M 10-Q · filed 2016-11-03 | $1.16B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | $314.42M 10-Q · filed 2016-08-08 | $314.76M 10-Q · filed 2015-08-05 | $583.20M 10-Q · filed 2016-08-08 | $583.89M 10-Q · filed 2015-08-05 | $872.03M derived: sum of 3 quarters · filed 2017-02-27 | $1.04B derived: sum of 4 quarters · filed 2017-02-27 | ||
| 2015-03-31 | $268.78M 10-Q · filed 2016-05-02 | $269.12M 10-Q · filed 2015-05-05 | $557.60M derived: sum of 2 quarters · filed 2017-02-27 | $722.95M derived: sum of 3 quarters · filed 2017-02-27 | $933.62M derived: sum of 4 quarters · filed 2017-02-27 | |||
| 2014-12-31 | $288.82M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $454.17M derived: sum of 2 quarters · filed 2017-02-27 | $664.84M derived: sum of 3 quarters · filed 2017-02-27 | $842.17M 10-K · filed 2017-02-27 | $843.93M 10-K · filed 2015-03-02 | |||
| 2014-09-30 | $165.35M 10-Q · filed 2015-11-02 | $165.64M 10-Q · filed 2014-10-28 | $376.01M derived: sum of 2 quarters · filed 2015-11-02 | $553.35M 10-Q · filed 2015-11-02 | $554.32M 10-Q · filed 2014-10-28 | $753.21M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-06-30 | $210.67M 10-Q · filed 2015-08-05 | $388.68M 10-Q · filed 2015-08-05 | $587.86M derived: sum of 3 quarters · filed 2016-02-29 | $775.46M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $178.01M 10-Q · filed 2015-05-05 | $377.19M derived: sum of 2 quarters · filed 2016-02-29 | $564.79M derived: sum of 3 quarters · filed 2016-02-29 | $721.65M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $199.18M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $386.78M derived: sum of 2 quarters · filed 2016-02-29 | $543.64M derived: sum of 3 quarters · filed 2016-02-29 | $704.49M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | $187.60M 10-Q · filed 2014-10-28 | $344.46M derived: sum of 2 quarters · filed 2014-10-28 | $505.31M 10-Q · filed 2014-10-28 | $684.15M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-06-30 | $156.86M 10-Q · filed 2014-07-31 | $317.71M 10-Q · filed 2014-07-31 | $496.55M derived: sum of 3 quarters · filed 2015-03-02 | $635.16M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-03-31 | $160.85M 10-Q · filed 2014-05-02 | $339.69M derived: sum of 2 quarters · filed 2015-03-02 | $478.30M derived: sum of 3 quarters · filed 2015-03-02 | $633.27M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2012-12-31 | $178.84M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $317.45M derived: sum of 2 quarters · filed 2015-03-02 | $472.42M derived: sum of 3 quarters · filed 2015-03-02 | $610.94M 10-K · filed 2015-03-02 | ||||
| 2012-09-30 | $138.61M 10-Q · filed 2013-10-28 | $293.58M derived: sum of 2 quarters · filed 2013-10-28 | $432.10M 10-Q · filed 2013-10-28 | $561.38M derived: sum of 4 quarters · filed 2014-02-26 | ||||
| 2012-06-30 | $154.97M 10-Q · filed 2013-07-29 | $293.49M 10-Q · filed 2013-07-29 | $422.77M derived: sum of 3 quarters · filed 2014-02-26 | $551.71M derived: sum of 4 quarters · filed 2014-02-26 | ||||
| 2012-03-31 | $138.51M 10-Q · filed 2013-04-29 | $267.80M derived: sum of 2 quarters · filed 2014-02-26 | $396.74M derived: sum of 3 quarters · filed 2014-02-26 | $506.60M derived: sum of 4 quarters · filed 2014-02-26 | ||||
| 2011-12-31 | $129.28M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $258.22M derived: sum of 2 quarters · filed 2014-02-26 | $368.09M derived: sum of 3 quarters · filed 2014-02-26 | $475.25M 10-K · filed 2014-02-26 | ||||
| 2011-09-30 | $128.94M 10-Q · filed 2012-10-29 | $238.81M derived: sum of 2 quarters · filed 2012-10-29 | $345.97M 10-Q · filed 2012-10-29 | $450.93M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-06-30 | $109.86M 10-Q · filed 2012-08-02 | $217.03M 10-Q · filed 2012-08-02 | $321.99M derived: sum of 3 quarters · filed 2013-02-26 | $421.68M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-03-31 | $107.16M 10-Q · filed 2012-04-30 | $212.13M derived: sum of 2 quarters · filed 2013-02-26 | $311.81M derived: sum of 3 quarters · filed 2013-02-26 | $400.72M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2010-12-31 | $104.96M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $204.65M derived: sum of 2 quarters · filed 2013-02-26 | $293.56M derived: sum of 3 quarters · filed 2013-02-26 | $375.72M 10-K · filed 2013-02-26 | ||||
| 2010-09-30 | $99.69M 10-Q · filed 2011-10-31 | $188.60M derived: sum of 2 quarters · filed 2011-10-31 | $270.76M 10-Q · filed 2011-10-31 | $351.46M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-06-30 | $88.91M 10-Q · filed 2011-08-01 | $171.07M 10-Q · filed 2011-08-01 | $251.77M derived: sum of 3 quarters · filed 2012-02-22 | $322.44M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-03-31 | $82.16M 10-Q · filed 2011-04-29 | $162.86M derived: sum of 2 quarters · filed 2012-02-22 | $233.54M derived: sum of 3 quarters · filed 2012-02-22 | $312.01M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2009-12-31 | $80.70M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $151.37M derived: sum of 2 quarters · filed 2012-02-22 | $229.85M derived: sum of 3 quarters · filed 2012-02-22 | $308.23M 10-K · filed 2012-02-22 | ||||
| 2009-09-30 | $70.67M 10-Q · filed 2010-10-29 | $149.15M derived: sum of 2 quarters · filed 2010-10-29 | $227.53M 10-Q · filed 2010-10-29 | |||||
| 2009-06-30 | $78.47M 10-Q · filed 2010-08-04 | $156.85M 10-Q · filed 2010-08-04 | ||||||
| 2008-12-31 | $256.74M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |